NCT00003903View on ClinicalTrials.gov

Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
OsteoporosisProstate Cancer
Interventions
PROCEDURE

management of therapy complications

Trial Locations (1)

14642-0001

James P. Wilmot Cancer Center, Rochester

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Rochester

OTHER

NCT00003903 - Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer | Biotech Hunter | Biotech Hunter